top of page
Filter posts by:
News
PBM Accountability Project Statement on Critical PBM Reforms in Congress
Many Congressional leaders and stakeholders continue to highlight the need for the PBM reforms. Representative Buddy Carter (R-GA)...
Mar 28
PBM Accountability Project Statement on House Introduction of Critical PBM Reforms
Representatives Mariannette Miller-Meeks, M.D. (R-IA), Nannette Barragan (D-CA), Nicole Malliotakis (R-NY), Brad Schneider (D-IL), Rick...
Mar 18
Letter to the Editor: The broken 340B drug program needs to be fixed
All North Dakotans surely know the adage, “If it ain’t broke, don’t fix it.” Well, some North Dakota state lawmakers are test-driving a...
Mar 14
ICYMI: Rural Americans Need PBM Reform Now
Millions of rural Americans face a devastating health crisis. They suffer from high rates of chronic diseases yet face a severe shortage...
Mar 12
The 340B Drug Pricing Program: A Patient Benefit or PBM Profit Center?
Recent public financial disclosures from major health insurance conglomerates like CVS Health have shed light on a concerning trend: the...
Mar 7
House Energy and Commerce Subcommittee Members Highlight the Need for Urgent PBM Reforms
Last week, the House Energy and Commerce Committee’s Subcommittee on Health held a hearing entitled, “An Examination of How Reining in...
Mar 4
PBM Accountability Project Statement on Senate Introduction of Critical PBM Reforms
Senators Grassley and Cantwell Continue Efforts to Ensure Patients, Employers and Unions No Longer Overpay for Prescriptions Feb. 13,...
Feb 13
PBM Accountability Project Joins Leading Stakeholders Urging Congress, President Trump to Prioritize PBM Reforms
The PBM Accountability Project recently joined several pharmacy, employer, and consumer advocates to encourage the new administration and...
Feb 5
PBM Accountability Project Calls on Congress to Pass PBM Reforms, Lower Prescription Drug Costs for all Americans
Doug Dority, Chairman of the Board of the PBM Accountability Project, recently penned a letter to House and Senate leadership urging...
Jan 28
PBM Accountability Project Calls on Congress to Pass CR with PBM Reforms
Doug Dority, Chairman of the Board of the PBM Accountability Project, penned a letter today to House and Senate leadership urging...
Dec 18, 2024
Congress Must Protect Consumers from PBM Abuse
The post-election lame duck session of Congress could be one of the most influential for consumers – if our elected officials are willing...
Dec 5, 2024
ICYMI: Medicare Pays Wildly Different Prices for the Same Drug
Middlemen negotiate prescription costs at thousands of different price points, depending on your insurance plan The cost of prescription...
Nov 26, 2024
PBM Accountability Project Statement on Governor Newsom Veto of SB 966
California Governor Gavin Newsom (D) has vetoed CA SB966 , legislation which would increase transparency and accountability of pharmacy...
Oct 1, 2024
It’s Time For The Truth On The High Cost Of Drugs
Make no mistake , our medicines, like everything else these days, cost far more than they should. Rather than acknowledging the actual...
Sep 25, 2024
PBM Accountability Project Statement on FTC Legal Action Against “The Big 3” PBMs
The Federal Trade Commission last week filed a suit accusing the three largest pharmacy benefit managers, or PBMs, of using their market...
Sep 23, 2024
The Biden-Harris Administration Must Side With Patients Against Big Insurers' Illegal Greed
President Joe Biden, Vice President Kamala Harris, and U.S. Department of Health and Human Services Secretary Xavier Becerra have a...
Aug 24, 2024
PBMs are Misleading America
As Congress investigates the pharmacy benefit manager (PBM) problem, these middlemen corporations continue steering patients away from...
Aug 19, 2024
Parties Agree — Lawmakers Need to Stop Drug Price Manipulation
The evidence against pharmacy benefit managers, or PBMs, has been piling up. Congress and multiple state legislatures have held hearings...
Aug 16, 2024
National Poll of Likely 2024 Voters Shows Strong Bipartisan Support for Specific PBM Reform Policies and Candidates Who Support Them
Likely Voters Want Policies to Require PBM Middlemen to Provide Value, Lower Out-of-Pocket Prescription Drug Costs Washington, DC – On...
Aug 1, 2024
PBM Accountability Project Members Host Important PBM Discussion on Capitol Hill
On Wednesday, July 9, the National Community Pharmacists Association (NCPA) and Coalition of State Rheumatology Organizations (CSRO) –...
Jul 23, 2024
PBM Accountability Project Statement on FTC Interim Report on PBMs
The Federal Trade Commission on July 9 issued its interim report on prescription drug middlemen known as pharmacy benefit managers or...
Jul 10, 2024
ICYMI: Mail-Order Drugs Were Supposed to Keep Costs Down. It’s Doing the Opposite.
One employer was paying about $100 for a prescription for a generic antidepressant, though it could be bought elsewhere for about $12 A...
Jun 25, 2024
ICYMI: New York Times Investigation Shows PBMs Rip Off Just About Everyone
The New York Times has published a detailed investigation into how middlemen pharmacy benefit managers (PBMs) drive up drug costs for...
Jun 21, 2024
Watch: How pharmacy benefit managers influence drug pricing
This is Part 2 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. Watch here >
Jun 12, 2024
bottom of page